The prevalence of type 2 idiopathic macular telangiectasia in two african populations

Ophthalmic Epidemiology

Volumn 19, Issue 4, 2012, Pages 185-189

  Sallo, Ferenc B ^a   Leung, Irene ^a   Mathenge, Wanjiku ^b,c   Kyari, Fatima ^b,d   Kuper, Hannah ^b   Gilbert, Clare E ^b   Bird, Alan C ^a   Peto, Tunde ^a  

^a MOORFIELDS EYE HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Rift Valley Provincial Hospital   (Kenya)

^d National Eye Centre   (Nigeria)

Author keywords

Imaging; Macular telangiectasia; Phenotype; Prevalence; Retina

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CLINICAL FEATURE; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HEALTH SURVEY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RURAL AREA; SUBRETINAL NEOVASCULARIZATION; TELANGIECTASIA; TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA; URBAN AREA; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; KENYA; MALE; MIDDLE AGED; NIGERIA; PHENOTYPE; PREVALENCE; RETINAL TELANGIECTASIS; VISUAL ACUITY;

EID: 84863669261     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2011.638744     Document Type: Article

References (14)

1. Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol 1982;100(5):769-780.
2. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology 1993;100(10):1536- 1546.
3. Yannuzzi LA, Bardal AM, Freund KB, Chen KJ, Eandi CM, Blodi B. Idiopathic macular telangiectasia. Arch Ophthalmol 2006;124(4):450-460.
4. Charbel Issa P, Holz FG, Scholl HP. Metamorphopsia in patients with macular telangiectasia type 2. Doc Ophthalmol 2009;119(2):133-140.
5. Klein R, Blodi BA, Meuer SM, Myers CE, Chew EY, Klein BE. The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study. Am J Ophthalmol 2010;150(1):55-62 e2.
6. Aung KZ, Wickremasinghe SS, Makeyeva G, Robman L, Guymer RH. The prevalence estimates of macular telangiectasia type 2: The Melbourne Collaborative Cohort Study. Retina 2010;30(3):473-478.
7. Dineen B, Gilbert CE, Rabiu M, et al. The Nigerian national blindness and visual impairment survey: Rationale, objectives and detailed methodology. BMC Ophthalmol 2008;8:17.
8. Kyari F, Gudlavalleti MV, Sivsubramaniam S, et al. Prevalence of blindness and visual impairment in Nigeria: The National Blindness and Visual Impairment Study. Invest Ophthalmol Vis Sci 2009;50(5):2033-2039.
9. Taylor HR. Applying new design principles to the construction of an illiterate E chart. Am J Optom Physiol Opt 1978;55(5):348-351.
10. Bourne RR, Rosser DA, Sukudom P, et al. Evaluating a new logMAR chart designed to improve visual acuity assessment in population-based surveys. Eye (Lond) 2003;17(6):754-758.
11. Rosser DA, Laidlaw DA, Murdoch IE. The development of a 'reduced logMAR' visual acuity chart for use in routine clinical practice. Br J Ophthalmol 2001;85(4):432-436.
12. Clemons TE, Gillies MC, Chew EY, et al. Baseline characteristics of participants in the natural history study of macular telangiectasia (MacTel). MacTel Project Report No. 2. Ophthalmic Epidemiol 2010;17(1):66-73.
13. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39(5):367-374.
14. Klein R, Davis MD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology 1991;98(7):1128-1134.